Literature DB >> 25033142

Assessment of hepatitis C risk factors and infection prevalence in a jail population.

Philip J Wenger1, Fred Rottnek, Todd Parker, Jeffrey S Crippin.   

Abstract

OBJECTIVES: We sought to validate previous reports of HCV prevalence in jails, identify HCV risk factors prevalence, and identify risk factors associated with HCV infection in this population.
METHODS: Inmates at the Buzz Westfall Justice Center (BWJC) in St. Louis, Missouri, were offered risk factor screening for HCV and anti-HCV antibody testing from December 2012 through May 2013. Demographic and risk factor information were assessed for significant associations with positive HCV antibody results. Risk factors that were significantly associated in univariate analysis were assessed using binary logistic regression to model the relationship between positive HCV results and the risk factors and demographics.
RESULTS: Fifty of 304 inmates were positive for HCV, with a prevalence of 16.4%. The risk factors significantly associated with increased risk for positive HCV antibody were age (odds ratio [OR] = 1.09; 95% confidence interval [CI] = 1.04, 1.15 for each year), injection drug use (OR = 53.87; 95% CI = 17.78, 163.21), sex with HCV-positive partner (OR = 7.35; 95% CI = 1.41, 38.20), and tattoos by a nonlicensed provider (OR = 2.62; 95% CI = 1.09, 6.33). Prevalence for women was 3 times that of men (38% vs 12%).
CONCLUSIONS: Prevalence of HCV at BWJC was similar to previous jail studies, which is lower than reported prison rates and higher than the general population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25033142      PMCID: PMC4151937          DOI: 10.2105/AJPH.2014.301996

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  16 in total

1.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

Review 2.  Natural history of chronic hepatitis C.

Authors:  Leonard B Seeff
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 3.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

4.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

5.  Screening for HCV infection in jails.

Authors:  Anne C Spaulding; David L Thomas
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

6.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

7.  The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

Authors:  Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

8.  Epidemiology of hepatocellular carcinoma in USA.

Authors:  Hashem B El-Serag
Journal:  Hepatol Res       Date:  2007-09       Impact factor: 4.288

9.  Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.

Authors:  Karen A Hennessey; Andrea A Kim; Vivian Griffin; Nicoline T Collins; Cindy M Weinbaum; Keith Sabin
Journal:  J Urban Health       Date:  2008-07-12       Impact factor: 3.671

10.  Chronic hepatitis C virus (HCV) disease burden and cost in the United States.

Authors:  Homie Razavi; Antoine C Elkhoury; Elamin Elbasha; Chris Estes; Ken Pasini; Thierry Poynard; Ritesh Kumar
Journal:  Hepatology       Date:  2013-05-06       Impact factor: 17.425

View more
  10 in total

1.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

2.  Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.

Authors:  Caroline M Abe; Merilyne Aguwa; Michelle Zhao; Jacqueline Sullivan; Esmaeil Porsa; Ank E Nijhawan
Journal:  Public Health Rep       Date:  2019-09-17       Impact factor: 2.792

3.  Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.

Authors:  Matthew J Akiyama; Fatos Kaba; Zachary Rosner; Howard Alper; Aimee Kopolow; Alain H Litwin; Homer Venters; Ross MacDonald
Journal:  Public Health Rep       Date:  2016-12-14       Impact factor: 2.792

Review 4.  Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.

Authors:  Selin Ocal; Andrew J Muir
Journal:  Curr HIV/AIDS Rep       Date:  2020-02       Impact factor: 5.071

5.  Hepatitis C in Canada and the importance of risk-based screening.

Authors:  S Ha; S Totten; L Pogany; J Wu; M Gale-Rowe
Journal:  Can Commun Dis Rep       Date:  2016-03-03

6.  Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice system.

Authors:  Justin C Strickland; Michele Staton; Carl G Leukefeld; Carrie B Oser; J Matthew Webster
Journal:  Int J Prison Health       Date:  2018-06-11

7.  Establishing an Epidemiologic Profile of Hepatitis C Virus Infection at the Los Angeles County Jail.

Authors:  Nazia Qureshi; Martha Tadesse; NgocDung Tran; Sean Henderson
Journal:  Public Health Rep       Date:  2021-02-18       Impact factor: 2.792

8.  Effect of hepatitis C antiviral therapy on oral lichen planus and hyposalivation in inmates.

Authors:  Giuseppe Scelza; Alessandra Amato; Antonio Maria Pagano; Giuseppe De Matteis; Rosa Caruso; Antonio Scelza; Laura Sisalli; Sebastiana De Biasi; Francesca Marigliano; Mario Gagliardi; Stefano Martina; Alfredo Iandolo
Journal:  Ann Gastroenterol       Date:  2021-11-10

9.  Prevalence of Hepatitis C Virus in Tuberculosis Patients: A Systematic Review and Meta-Analysis.

Authors:  Meysam Behzadifar; Sanaz Heydarvand; Masoud Behzadifar; Nicola Luigi Bragazzi
Journal:  Ethiop J Health Sci       Date:  2019-01

10.  Characteristics associated with anti-HCV serological markers in prisoners in the state of Paraná, Brazil: a case-control study.

Authors:  Tânia Maria Pazin Marques Silva; Lirane Elize Defante Ferreto; Franciele Ani Caovilla Follador; Ana Paula Vieira; Roberto Shigueyasu Yamada; Léia Carolina Lucio; Joana Perotta Titon; Renata Himovski Torres; Greicy Cézar do Amaral; Harnoldo Colares Coelho
Journal:  Braz J Infect Dis       Date:  2019-06-20       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.